Journal of Clinical Epidemiology
Volume 58, Issue 1 , Pages 47-55 , January 2005

OAKHQOL: A new instrument to measure quality of life in knee and hip osteoarthritis

  • Anne-Christine Rat

      Affiliations

    • EA 3444, Service d'Epidémiologie et Evaluations Cliniques, Hôpital Marin - CHU de Nancy, Nancy, France
    • ,
  • Joël Coste

      Affiliations

    • Département de Biostatistique et d'Informatique Médicale, Hôpital Cochin, Paris, France
    • ,
  • Jacques Pouchot

      Affiliations

    • Service de Médecine Interne, Hôpital Louis Mourier, Colombes, France
    • ,
  • Michèle Baumann

      Affiliations

    • EA 3444, Service d'Epidémiologie et Evaluations Cliniques, Hôpital Marin - CHU de Nancy, Nancy, France
    • ,
  • Elizabeth Spitz

      Affiliations

    • Laboratoire de Psychologie de la Santé, UFR Sciences Humaines et Arts, Université de Metz, France
    • ,
  • Nathalie Retel-Rude

      Affiliations

    • Laboratoire de Biostatistiques Pharmaceutiques, Faculté de Médecine et de Pharmacie, Université de Franche-Comté, Besançon, France
    • ,
  • Janine-Sophie Le Quintrec

      Affiliations

    • Services de Rhumatologie et d'Orthopédie, Hôpital Cochin, Paris, France
    • ,
  • Dominique Dumont-Fischer

      Affiliations

    • Service de Rhumatologie, Hôpital Avicenne, Bobigny, France
    • ,
  • Francis Guillemin

      Affiliations

    • EA 3444, Service d'Epidémiologie et Evaluations Cliniques, Hôpital Marin - CHU de Nancy, Nancy, France
    • Corresponding Author InformationCorresponding author. Tel.: +33-38-385-2163; Fax: +33-38-385-1205.

,Accepted 2 April 2004.

References 

  1. Felson DT, Zhang Y, Hannan MT, Naimark A, Weissman BN, Aliabadi P, et al. The incidence and natural history of knee osteoarthritis in the elderly. The Framingham Osteoarthritis Study. Arthritis Rheum. 1995;38:1500–1505
  2. Felson DT, Zhang Y. An update on the epidemiology of knee and hip osteoarthritis with a view to prevention. Arthritis Rheum. 1998;41:1343–1355
  3. Hart DJ, Doyle DV, Spector TD. Incidence and risk factors for radiographic knee osteoarthritis in middle-aged women: the Chingford Study. Arthritis Rheum. 1999;42:17–24
  4. Gabriel SE, Crowson CS, Campion ME, O'Fallon WM. Direct medical costs unique to people with arthritis. J Rheumatol. 1997;24:719–725
  5. Gabriel SE, Crowson CS, Campion ME, O'Fallon WM. Indirect and nonmedical costs among people with rheumatoid arthritis and osteoarthritis compared with nonarthritic controls. J Rheumatol. 1997;24:43–48
  6. Lapsley HM, March LM, Tribe KL, Cross MJ, Brooks PM. Living with osteoarthritis: patient expenditures, health status, and social impact. Arthritis Rheum. 2001;45:301–306
  7. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol. 1988;15:1833–1840
  8. Lequesne MG, Mery C, Samson M, Gerard P. Indexes of severity for osteoarthritis of the hip and knee. Validation–value in comparison with other assessment tests. Scand J Rheumatol Suppl. 1987;65:85–89
  9. FDA. Guidance for industry. Clinical development programs for drugs, devices and biological products intended for the treatment of osteoarthritis (OA) 1999. Available at: http://www.fda.gov/cber/gdlns/osteo. Accessed July 2, 2003.
  10. Pouchot J, Joubert J, Bono I. Apport des instruments de mesure d'incapacité fonctionnelle et de qualité de vie dans l'arthrose [Contribution of functional disability and quality of life measures to the evaluation of patients with osteoarthritis.]. Rev Rhum. 1995;62:56S–63S
  11. Mainard D, Guillemin F, Cuny C, Mejat-Adler E, Galois L, Delagoutte J. Evaluation à un an de la qualité de vie après arthroplastie totale de hanche et de genou. [Quality of life assessment one year after total hip or knee arthroplasty.] Rev Chir Orthop Reparatrice Appar Mot. 2000;86:464–473
  12. Bombardier C, Melfi CA, Paul J, Green R, Hawker G, Wright J, et al. Comparison of a generic and a disease-specific measure of pain and physical function after knee replacement surgery. Med Care. 1995;33:AS131–AS144
  13. Hawker G, Melfi C, Paul J, Green R, Bombardier C. Comparison of a generic (SF-36) and a disease specific (WOMAC) (Western Ontario and McMaster Universities Osteoarthritis Index) instrument in the measurement of outcomes after knee replacement surgery. J Rheumatol. 1995;22:1193–1196
  14. Mangione CM, Goldman L, Orav EJ, Marcantonio ER, Pedan A, Ludwig LE, et al. Health-related quality of life after elective surgery: measurement of longitudinal changes. J Gen Intern Med. 1997;12:686–697
  15. Lieberman JR, Dorey F, Shekelle P, Schumacher L, Kilgus DJ, Thomas BJ, et al. Outcome after total hip arthroplasty. Comparison of a traditional disease-specific and a quality-of-life measurement of outcome. J Arthroplasty. 1997;12:639–645
  16. Heck DA, Robinson RL, Partridge CM, Lubitz RM, Freund DA. Patient outcomes after knee replacement. Clin Orthop. 1998;93–110
  17. Patrick DL, Deyo RA. Generic and disease-specific measures in assessing health status and quality of life. Med Care. 1989;27:S217–S232
  18. Pouchot J, Guillemin F, Coste J, Bregeon C, Sany J. Validity, reliability, and sensitivity to change of a French version of the arthritis impact measurement scales 2 (AIMS2) in patients with rheumatoid arthritis treated with methotrexate. J Rheumatol. 1996;23:52–60
  19. Guillemin F, Coste J, Pouchot J, Ghezail M, Bregeon C, Sany J. The AIMS2-SF: a short form of the Arthritis Impact Measurement Scales 2. French Quality of Life in Rheumatology Group. Arthritis Rheum. 1997;40:1267–1274
  20. Ren XS, Kazis L, Meenan RF. Short-form Arthritis Impact Measurement Scales 2: tests of reliability and validity among patients with osteoarthritis. Arthritis Care Res. 1999;12:163–171
  21. Meenan RF, Mason JH, Anderson JJ, Guccione AA, Kazis LE. AIMS2. The content and properties of a revised and expanded Arthritis Impact Measurement Scales Health Status Questionnaire. Arthritis Rheum. 1992;35:1–10
  22. Fielden JM, Gander PH, Horne JG, Lewer BM, Green RM, Devane PA. An assessment of sleep disturbance in patients before and after total hip arthroplasty. J Arthroplasty. 2003;18:371–376
  23. Fitzgerald JD, Orav EJ, Lee TH, Marcantonio ER, Poss R, Goldman L, et al. Patient quality of life during the 12 months following joint replacement surgery. Arthritis Rheum. 2004;51:100–109
  24. The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med. 1995;41:1403–1409
  25. Stucki G, Sigl T. Assessment of the impact of disease on the individual. Best Pract Res Clin Rheumatol. 2003;17:451–473
  26. Stucki G, Ewert T, Cieza A. Value and application of the ICF in rehabilitation medicine. Disabil Rehabil. 2002;24:932–938
  27. Guillemin F, Coste J, Retel-Rude N, Spitz E, Baumann M, Tarquino C, et al. The French Group Quality of Life in Rheumatology. Strategy and methodology for choice of items in psychometric measurement: designing a quality of life instrument for of hip and knee osteoarthritis. In:  Mesbah M,  Cole BF,  Ting Lee ML editor. Statistical methods for quality of life studies: design, measurements and analysis. Dordrecht: Kluwer Academic Publishers; 2002;p. 51–61
  28. Fisher RP, Falkner KL, Trevisan M, McCauley MR. Adapting the cognitive interview to enhance long-term (35 years) recall of physical activities. J Appl Psychol. 2000;85:180–189
  29. Altman R, Alarcon G, Appelrouth D, Bloch D, Borenstein D, Brandt K, et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum. 1991;34:505–514
  30. Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum. 1986;29:1039–1049
  31. Ware JE, Kosinski M, Keller SK. SF-36 physical and mental health summary scale: a user's manual. Boston, MA: The Health Institute; 1994;
  32. Streiner D, Norman G. Health measurement scales: a practical guide to their development and use. Ed 2. New York: Oxford University Press; 1995;231
  33. Coste J, Fermanian J, Venot A. Methodological and statistical problems in the construction of composite measurement scales: a survey of six medical and epidemiological journals. Stat Med. 1995;14:331–345
  34. Shrout PE. Measurement reliability and agreement in psychiatry. Stat Methods Med Res. 1998;7:301–317
  35. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307–310
  36. Ware JE, Gandek B. Methods for testing data quality, scaling assumptions, and reliability: the IQOLA Project approach. International Quality of Life Assessment. J Clin Epidemiol. 1998;51:945–952
  37. Hays RD, Wang EYI. Multitrait scaling program: MULTI [RAND, University of Southern California] 2003. Available at: http://www.rand.org/publications/MR/MR162/.appc.pdf. Accessed July 2, 2003.
  38. McKenna SP, Hunt SM. A new measure of quality of life in depression: testing the reliability and construct validity of the QLDS. Health Policy. 1992;22:321–330
  39. Whalley D, McKenna SP, de Jong Z, van der Heijde D. Quality of life in rheumatoid arthritis. Br J Rheumatol. 1997;36:884–888
  40. Doward LC, Spoorenberg A, Cook SA, Whalley D, Helliwell PS, Kay LJ, et al. Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis. Ann Rheum Dis. 2003;62:20–26
  41. Kaplan RM, Anderson JP, Wu AW, Mathews WC, Kozin F, Orenstein D. The Quality of Well-being Scale. Applications in AIDS, cystic fibrosis, and arthritis. Med Care. 1989;27:S27–S43
  42. Juniper EF, Guyatt GH, Epstein RS, Ferrie PJ, Jaeschke R, Hiller TK. Evaluation of impairment of health-related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax. 1992;47:76–83
  43. Greene J, McClintock C. Triangulation in evaluation, design, and analysis issues. Evaluation Review. 1985;9:523–545
  44. Maggs-Rapport F. Combining methodological approaches in research: ethnography and interpretive phenomenology. J Adv Nurs. 2000;31:219–225
  45. Coste J, Guillemin F, Pouchot J, Fermanian J. Methodological approaches to shortening composite measurement scales. J Clin Epidemiol. 1997;50:247–252
  46. Ware JE, Gandek B. Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project. J Clin Epidemiol. 1998;51:903–912
  47. Leplege A, Ecosse E, Verdier A, Perneger TV. The French SF-36 Health Survey: translation, cultural adaptation, and preliminary psychometric evaluation. J Clin Epidemiol. 1998;51:1013–1023
  48. Poiraudeau S, Chevalier X, Conrozier T, Flippo RM, Liote F, Noel E, et al. Reliability, validity, and sensitivity to change of the Cochin hand functional disability scale in hand osteoarthritis. Osteoarthritis Cartilage. 2001;9:570–577
  49. Kopec JA, Esdaile JM, Abrahamowicz M, Abenhaim L, Wood-Dauphinee S, Lamping DL, et al. The Quebec Back Pain Disability Scale. Measurement properties. Spine. 1995;20:341–352
  50. Guillemin F, Bombardier C, Beaton D. Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol. 1993;46:1417–1432
  51. Beaton DE, Bombardier C, Guillemin F, Ferraz MB. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine. 2000;25:3186–3191

PII: S0895-4356(04)00179-9

doi: 10.1016/j.jclinepi.2004.04.011

Journal of Clinical Epidemiology
Volume 58, Issue 1 , Pages 47-55 , January 2005

Article Tools